# Linkhome Holdings Inc.: overview

LHAI · Nasdaq · CIK 2017758 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lhai.md) · [Financials](/companies/lhai/financials.md) · [Filings](/companies/lhai/filings.md) · [Insiders](/companies/lhai/insiders.md)

Latest reported revenue: [$5.4m](/filings/0001213900-26-088401.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-088401).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [235](/filings/0001213900-25-110060.md) | [7,030 d](/filings/0001213900-26-059081.md) | [5,709](/filings/0001213900-26-063480.md) | [4,800](/filings/0001213900-26-088401.md) | [5,408](/filings/0001213900-25-110060.md) | [5,175 d](/filings/0001213900-26-059081.md) | [4,907](/filings/0001213900-26-063480.md) | [5,412](/filings/0001213900-26-088401.md) |
| Gross margin | % | [214.8%](/filings/0001213900-25-110060.md) | [8.3% d](/filings/0001213900-26-059081.md) | [4.6%](/filings/0001213900-26-063480.md) | [2.3%](/filings/0001213900-26-088401.md) | [3.8%](/filings/0001213900-25-110060.md) | [3.8% d](/filings/0001213900-26-059081.md) | [3.8%](/filings/0001213900-26-063480.md) | [2.9%](/filings/0001213900-26-088401.md) |
| Operating margin | % | [171.1%](/filings/0001213900-25-110060.md) | [7.8% d](/filings/0001213900-26-059081.md) | [2.2%](/filings/0001213900-26-063480.md) | [0.3%](/filings/0001213900-26-088401.md) | [0.2%](/filings/0001213900-25-110060.md) | [(1.4%) d](/filings/0001213900-26-059081.md) | [(4.4%)](/filings/0001213900-26-063480.md) | [(3.6%)](/filings/0001213900-26-088401.md) |
| Net margin | % | [121.0%](/filings/0001213900-25-110060.md) | [5.7% d](/filings/0001213900-26-059081.md) | [1.4%](/filings/0001213900-26-063480.md) | [0.3%](/filings/0001213900-26-088401.md) | [(0.0%)](/filings/0001213900-25-110060.md) | [(0.4%) d](/filings/0001213900-26-059081.md) | [(2.7%)](/filings/0001213900-26-063480.md) | [(2.4%)](/filings/0001213900-26-088401.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.01](/filings/0001213900-26-063480.md) | [0.00](/filings/0001213900-26-088401.md) | not reported | not reported | [(0.01)](/filings/0001213900-26-063480.md) | [(0.01)](/filings/0001213900-26-088401.md) |
| Free cash flow | $k | [(2,508) d](/filings/0001213900-25-110060.md) | not reported | [(1,760)](/filings/0001213900-26-063480.md) | [(2,826) d](/filings/0001213900-26-088401.md) | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [1.4](/filings/0001013762-25-003420.md) | [7.6](/filings/0001213900-26-059081.md) | [21.0](/filings/0001213900-26-059081.md) |
| Gross margin | % | [18.4%](/filings/0001013762-25-003420.md) | [19.3%](/filings/0001213900-26-059081.md) | [3.7%](/filings/0001213900-26-059081.md) |
| Operating margin | % | [11.6%](/filings/0001013762-25-003420.md) | [14.3%](/filings/0001213900-26-059081.md) | [0.4%](/filings/0001213900-26-059081.md) |
| Net margin | % | [11.0%](/filings/0001013762-25-003420.md) | [10.2%](/filings/0001213900-26-059081.md) | [0.4%](/filings/0001213900-26-059081.md) |
| Diluted EPS | $ per share | not reported | [0.05](/filings/0001213900-26-059081.md) | [0.00](/filings/0001213900-26-059081.md) |
| Free cash flow | $m | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lhai/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-19 | [US Innovation Foundation](/insiders/2158407.md) | 10% owner | Sale (S) | 315,000 | $0.785 | $247.3k | [Form 4](/filings/0001213900-26-112127.md) |
| 2026-10-19 | [US Innovation Foundation](/insiders/2158407.md) | 10% owner | Sale (S) | 935,000 | $0.50 | $467.5k | [Form 4](/filings/0001213900-26-112127.md) |
| 2026-10-19 | [US Innovation Foundation](/insiders/2158407.md) | 10% owner | Sale (S) | 840,000 | $0.50 | $420.0k | [Form 4](/filings/0001213900-26-112127.md) |
| 2026-10-19 | [US Innovation Foundation](/insiders/2158407.md) | 10% owner | Sale (S) | 930,000 | $0.50 | $465.0k | [Form 4](/filings/0001213900-26-112127.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $39.9k | 60,401 |  | New +60,401 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $20.8k | 31,523 |  | New +31,523 |
| [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $12.9k | 19,506 |  | Reduced −823 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $7.8k | 11,789 |  | New +11,789 |
| [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.3k | 5,026 |  | Added +2,963 |
| [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $1.0k | 919 |  | Added +905 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $658 | 997 |  | Reduced −3,185 |
| [Steward Partners Investment Advisory, LLC](/funds/1723397.md) | 2026-06-30 | $626 | 948 |  | Unchanged |
| [HRT FINANCIAL LP](/funds/1475597.md) | 2026-06-30 | $21 | 31,894 |  | New +31,894 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $5 | 8 |  | New +8 |

## Recent filings

[All 82 filings](/companies/lhai/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 23:13 ET | [SCHEDULE 13D](/filings/0001213900-26-110399.md) | Ownership report, active investor | 0001213900-26-110399 |
| 2026-10-01 | 20:11 ET | [8-K](/filings/0001213900-26-105784.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-105784 |
| 2026-09-21 | 20:30 ET | [8-K](/filings/0001213900-26-101820.md) | 3.01 Delisting notice | 0001213900-26-101820 |
| 2026-09-10 | 20:09 ET | [8-K/A](/filings/0001213900-26-098789.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001213900-26-098789 |
| 2026-09-02 | 20:06 ET | [8-K](/filings/0001213900-26-096701.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-096701 |
| 2026-08-12 | 20:31 ET | [10-Q](/filings/0001213900-26-088401.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088401 |
| 2026-07-17 | 21:00 ET | [8-K](/filings/0001213900-26-079237.md) | 5.07 Shareholder vote results | 0001213900-26-079237 |
| 2026-07-02 | 21:00 ET | [8-K](/filings/0001213900-26-075071.md) | 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-075071 |
| 2026-06-22 | 20:01 ET | [DEF 14A](/filings/0001213900-26-070605.md) | Proxy statement, period 2026-07-15 | 0001213900-26-070605 |
| 2026-06-01 | 20:02 ET | [10-Q/A](/filings/0001213900-26-063480.md) | Quarterly report, amended, period 2026-03-31 | 0001213900-26-063480 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-034538.md), filed Mar 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/5c96f22d-1dd1-4fd6-8934-13e86453bc1f)

## About the filer

- CIK: 2017758
- Tickers: LHAI
- Exchange: Nasdaq
- SIC code: 6531 Real Estate Agents & Managers (For Others)
- State of incorporation: NV
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.